Detalles de la búsqueda
1.
Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues.
Org Biomol Chem;
19(41): 8968-8987, 2021 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596646
2.
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
J Exp Clin Cancer Res;
42(1): 260, 2023 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803448
3.
Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
Drug Des Devel Ther;
15: 5035-5059, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949914
4.
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids.
Mol Cancer Ther;
19(7): 1506-1519, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32371581
Resultados
1 -
4
de 4
1
Próxima >
>>